Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

TON - October 2020, Vol 13, No 5

TON June 2020, Vol 13, No 3 Cover

I was very honored to be asked to take the reins as the new Editor-in-Chief of The Oncology Nurse-APN/PA (TON) by the founding Editor-in-Chief Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN. Although Beth will be a hard act to follow, I will do my best to maintain the high standards she has established for the journal
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) in Baltimore is a National Cancer Institute–designated comprehensive cancer center, a distinction that places it in the top tier of cancer institutions in the United States.
During the COVID-19 pandemic, oncology nurses have been the cornerstone of healthcare services, whether they are on the front lines offering compassionate care or in a leadership role developing and implementing new policies to promote better patient outcomes.
Results from 2 studies highlight the increasingly important role of germline testing in the management of patients with cancer. These findings were presented by Zsofia K. Stadler, MD, Medical Oncologist, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York City.
For decades, healthcare professionals have worked diligently to teach individuals that screening is a valuable tool for preventing and detecting cancer. This has not been an easy mission, and nurses and physicians have had to debunk the myths, bias, and misinformation that deter patients from getting screened annually or according to specific guidelines set forth by organizations such as the Centers for Disease Control and Prevention (CDC) and the American Cancer Society (ACS).
Until the late 1930s, stomach cancer—also called gastric cancer—was the leading cause of cancer death in the United States. Although stomach cancer is still a major cause of cancer-related deaths worldwide, it is now much less common in this country. The following provides a brief look at some of the key statistics regarding this disease.
Employers are not likely to make major changes in their benefit designs for 2021, said experts in an August 12 webcast sponsored by the Association for Value-Based Cancer Care. Art Taft, MBA, MEng, Managing Director, MedWorks, moderated the session with F. Randy Vogenberg, PhD, RPh, FASHP, Board Chair, Employer-Provider Interface Council, Hospital Quality Foundation, and Principal, Institute for Integrated Healthcare; and James Startare, MS, Vice President of Benefits, Aramark, the food services, facilities, and uniform provider, which has more than 270,000 employees in 19 countries.
Leading global drug manufacturers have been called on to respond to the COVID-19 pandemic in myriad ways, and several of their top executives discussed those responses in an August 11 webcast sponsored by the Association for Value-Based Cancer Care.
  • Selpercatinib Shows Durable Responses in Patients with Thyroid Cancer and RET Mutation
  • Venclexta plus Azacitidine Improves Overall Survival in Patients with AML
  • Advances in New Therapies Attributed to Reductions in Lung Cancer Mortality
Cancer health disparities remain a challenge in the United States, despite some strides being made to reduce these disparities, according to a new report from the American Association for Cancer Research (AACR) that was released in a virtual presentation on September 16, 2020.
Page 1 of 2
Results 1 - 10 of 14